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ABSTRACT 
The evidence to support the effectiveness of home telemonitoring interventions for patients 
with COPD is limited yet there are many efforts made to implement these technologies 
across healthcare services. 
 
A comprehensive search strategy was designed and implemented across 9 electronic 
databases and 11 European, Australasian and North American telemedicine websites. 
Included studies had to examine the effectiveness of telemonitoring interventions, clearly 
defined for the study purposes, for adult patients with COPD. Two researchers independently 
screened each study prior to inclusion.  
 
Two randomised trials and four other evaluations of telemonitoring were included. The 
studies are typically underpowered, had heterogeneous patient populations and had a lack of 
detailed intervention descriptions and of the care processes that accompanied 
telemonitoring. In addition, there were diverse outcome measures and no economic 
evaluations. The telemonitoring interventions in each study differed widely. Some had an 
educational element that could itself account for the differences between groups. 
 
Despite these caveats, the study reports are themselves positive about their results. 
However, given the risk of bias in the design and scale of the evaluations we conclude 
that the benefit of telemonitoring for COPD is not yet proven and that further work is 
required before wide scale implementation be supported. 
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INTRODUCTION 
Interest in using home telemonitoring interventions to help manage patients with chronic 
obstructive pulmonary disease (COPD) is increasing, yet the evidence to support the 
effectiveness of these practices is limited.[1]  By 2020, COPD is predicted to become the 
third leading cause of death worldwide, and the fifth most common source of disability.[2] In 
order to try and facilitate the management of the growing number of patients with COPD and 
to reduce pressures on health services, providers have sought to implement telemonitoring 
for patients with COPD. However, whilst there are several substantive evaluations of the 
efficacy of telemonitoring interventions for conditions such as heart failure,[3,4,5] this is not 
the case for COPD and it is not clear whether these interventions are effective. 
 
A number of systematic reviews have evaluated the effectiveness of telemonitoring 
interventions for patients diagnosed with a heart failure and other long-term 
conditions.[6,7,8,9] The reviews are in the main positive and suggest that there is tentative 
evidence that telemonitoring may offer clinical benefit by reducing burden on services by 
reducing admissions. Yet the case for cost-effectiveness remains unsubstantiated and there 
is no evidence that telemonitoring efforts become part of routine practice after the protected 
funding and evaluations are completed.[10]  There is interest in adopting telemonitoring for 
patients with COPD given the possibility that technology could help diagnose exacerbations 
in time to reduce morbidity and perhaps admission to hospital. There are few studies 
however and scoping searches revealed only a handful of publications and no systematic 
reviews.[7,8,9] In addition, it is likely,[8] that the clinical and economic effectiveness of 
telemonitoring interventions would vary across the different chronic diseases and there is a 
need to examine the evidence for the effectiveness of telemonitoring specifically for COPD. 
 
We therefore conducted a systematic review of studies that have addressed the 
effectiveness of telemonitoring practices for patients with COPD. Our aim was to examine 
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the evidence for the clinical and economic benefit of telemonitoring interventions in this 
condition. 
 
METHOD 
The search strategy 
A comprehensive literature search was conducted January 1990 to July 2009 using the 
methods recommended by the NHS Centre for Reviews and Dissemination  and the 
Cochrane Collaboration.[11,12] Nine electronic databases (Medline, Scopus, INSPEC, the 
Science Citation Index, Embase, CINAHL, BNI, the Cochrane Library, the WHO Library) 
and 11 European, Australasian and North American telemedicine websites 
(www.teis.port.ac.uk; www.library.nhs.uk; www.telemedicine.scot.nhs.uk; 
www.telemedicine.org.uk; www.nlm.nih.gov; www.dh.gov.uk/www.pasa.nhs.uk; 
www.nordictelemedicine.org; www.ehto.org; www.tie.telemed.org; www.uq.edu.au; 
www.cst-sct.org) were searched for published articles. In order to identify in press and 
recently published articles, authors of included studies were contacted. The table of 
contents of selected relevant journals were manually screened and the bibliographies of 
all retained articles examined for relevant studies. 
 
Inclusion and exclusion criteria 
To be included, studies had to examine the effectiveness of telemonitoring interventions 
for adult patients with COPD. Scoping searches had indicated a paucity of research in 
this area and we therefore included uncontrolled and non-randomised as well as 
randomised controlled studies. All published studies reporting economic and clinically 
related outcomes (e.g. hospital admissions, number of exacerbations) were considered. 
Non-systematic review articles, single case, or case series reports were excluded. 
Articles that included additional medical conditions as well COPD were retained if the 
outcomes specific to the COPD group were reported separately. All English and non-
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English language studies identified during the search were considered. Non-English 
language titles and abstracts were reviewed by colleagues able to apply the criteria.  
 
A definition of telemonitoring 
Telemonitoring has been defined as ‘the use of telecommunication technologies by 
patients for the timely transmission of data (e.g. spirometric measures, vital signs and 
symptoms) from home to a healthcare service centre.[9] In this study we operationalised 
the definition further. In order to qualify as telemonitoring, the intervention had to; (1) 
require the patient or their carer to periodically measure physiological indicators (e.g. 
arterial oxygen saturation & heart rate) and/or record their symptoms/vital signs in a 
standardised format, (2) use telecommunication technologies (e.g. telephone, internet, 
web-phone) that either manually or automatically transferred the patients health status 
data from home to a healthcare service, (3) lead to the automated or manual review of 
the patient’s health status data, (4) involve an automated or manual response  when the 
patients health status data crossed a pre-defined threshold. Studies were excluded if 
healthcare professionals conducted the measurement of physiological signs. 
 
The screening process 
Two researchers independently screened each citation identified during the search and 
decided on the articles to retrieve for full text analysis. CSW extracted the data and 
attributed an evidence score to each study using the evidence levels suggested by the 
Oxford Centre for Evidence-based Medicine (http://www.cebm.net/index.aspx?o=1025). 
CSW also conducted a risk of bias assessment for each individual study according to the 
Cochrane Collaboration criteria. GE checked the data extraction; independently allocated 
a level of evidence score, and reviewed the bias assessments. Differences in opinion 
were resolved by discussion until consensus was achieved. 
Data extraction 
 6 
The following information was collated and tabulated from the included studies: 
description of patient population, sample size, presence of power calculation, duration of 
follow-up period and the type of economic evaluation (if any). The nature of the 
intervention and the outcomes reported were also summarised. 
 
RESULTS 
The search results are reported in Figure 1. 
 
Characteristics of the included studies 
 
Table 1 summarizes the characteristics and results of the 6 included research studies. 
Two of the six studies were randomised controlled trials,[13,14] two studies used a non-
randomised design with a control group,[15,16] and two used a non-randomised design 
without a control group.[17,18] All of the studies were conducted on relatively small 
samples. The follow-up period during the intervention ranged from three to twelve 
months. One study followed-up their participants for 12 months, three for six months, one 
for three months, and one study conducted a variable follow-up period of 3 to 12 months. 
All the articles were published after 2002.  
 
The patient populations recruited varied between studies. Most studies recruited patients 
during or following a hospital admission for COPD exacerbation or from secondary care 
clinics. Mean ages for participants ranged from 61 yrs to 73 yrs. Information regarding 
disease severity was variable. Mean FEV1 and proportion of patients on long term oxygen 
therapy (LTOT) were the most commonly reported measures of disease severity. Two of 
the studies specifically recruited patients who were on LTOT or home ventilation. [14,17]   
 
Figure 1  Summary of the review process  
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<<Insert Table 1 about Here>> 
 
Methodological quality 
 
All of the studies had methodological limitations. The quality of the study reports did not 
provide sufficient data for a risk of bias assessment. However, we do comment on 
methodological limitations in Table 1. Largely due to the small sample sizes, no study was 
classed higher than a level 2b in the hierarchy of evidence and only one trial by Koff et al. 
reported a sample size power calculation.[13] Of the randomised controlled trials, both report 
321 abstracts and titles 
screened for the 
appraisal of relevance 
40 papers full text 
retrieval  
78 excluded (reviews or 
discussion papers) 
 6 studies met the 
inclusion/exclusion 
criteria 
292 citations identified by 
database searches 29 by 
manual and online 
searches  
143 excluded (not 
telemonitoring) 
38 excluded (research 
method) 
22 excluded (not research 
on COPD) 
17 excluded (not COPD / 
telemonitoring) 
13 excluded (same study, 
reviews or discussion)  
4 excluded (no evaluation 
of clinical outcome)  
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the method of randomisation.[13,14] Due to the nature of the intervention, no study reported 
on allocation concealment. Attrition rates across the included studies were variable. 
Retention rates ranged between  70% [16] and 98% [14]. More recent studies tended to use 
larger samples and randomised designs, reflecting an improvement in design quality over 
time. The quality of the study reporting was low and it was difficult to establish clarity on 
many telemonitoring processes and outcome.  None of the trials reported their results using 
the CONSORT guidelines.[19]  
 
The nature of the telemonitoring intervention 
Four of the six studies had an educational component to their intervention programme. The 
trial by Parée provided a 1 to 2 hour educational session that offered information on the 
nature of COPD and strategies for the effective management of the condition.[15] The other 
three studies provided ongoing information throughout the course of the intervention on 
disease management and illness education via a web-based computerised 
programme.[13,16,18] The studies were in effect assessment of complex interventions that 
were composed of multiple components. It is not clear whether the educational strategies, 
the increased professional contact or the monitoring technologies had the most impact. It is 
likely that there is a synergistic effect of the different components and we need to be cautious 
about making inferences based on the role of the technology alone. 
Only Koff et al., Dang et al. and Vitacca et al. report any information about the type of 
symptom information collected or describe how this relates to the generation of alert 
situations and the healthcare professional’s response, [13,14,18] with Koff et al. and Vitacca 
et al. providing the most information.[13,14] Koff et al. reported a table of criteria by which 
green, yellow and red ‘flags’ were generated for each indicator.[13] Observing staff were 
alerted to contact patients with red flags and to use “discretion” for persistent yellow and red. 
Vitacca et al. used a card-based questioning by nurses to collect systematic health 
information and assign numerical scores and the criteria by which this information was 
categorised for each indicator was reproduced in their article.[14] A change of more than 
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three points from baseline would initiate a referral to a pulmonologist. None of the studies 
report the collected data in the results or assess the usefulness of the collected data in 
achieving the reported outcomes. 
 
The frequency of telemonitoring assessment or contact with the health care provider over the 
course of the follow-up period varied greatly across the included studies. In four studies, the 
intervention group was remotely monitored on a daily basis.[13,15,16,18] In one study the 
patients were monitored twice weekly.[17] 
 
<<Insert Table 2 about Here>> 
 
Table 2 summarises the telemonitoring components used in the included studies. Five of the 
six studies required the patients to record physiological indices of their health status (e.g. 
arterial oxygen saturation, pulmonary functioning).[13,14,15,17,18], four of the six studies 
relied on the patient’s subjective report of their symptoms and vital signs.[13,14,15,17] In 
these studies, the staff at a call centre recorded the patient’s responses to a set of questions 
that assessed the likelihood of an exacerbation given the severity of the patient’s symptoms. 
In the remaining studies, the physiological measures and/or the patients’ self-reported 
symptoms were recorded at home and transmitted via the internet to the healthcare provider.  
 
 
 
 
The effectiveness of the telemonitoring intervention.  
 
The effectiveness of the telemonitoring interventions were evaluated in terms of 
improvements in the patient’s medical condition and quality of life, reductions in health 
service utilisation and economic savings. The specific findings of each study are summarised 
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in Table 1. General trends are as follows. Four of the six studies examined whether 
participation in the telemonitoring intervention reduced the number of COPD 
exacerbations.[13,14,16,17] Two of these four studies reported a statistically significant 
reduction.[14,16] Two of the six studies examined the patient’s self-reported quality of 
life:[13,16] only one of these studies observed a significant improvement.[13] Only one of the 
six studies reported mortality as an outcome and did not find any reduction in mortality rate 
with the intervention.[14] 
 
Regarding health service utilisation,  all six reported hospital admissions with four observing 
a reduction in the number of hospital admissions among the patients enrolled in the 
intervention programme.[14,15,16,17] Often this related the admissions in the study period to 
the preceding comparative number of months. It is also not clear in the results whether the 
admissions were due to COPD exacerbations or not and to what degree treatment has been 
initiated early by virtue of telemonitoring. The two studies that conducted detailed cost-
minimisation analyses reported savings of 15% and 50% per patient.[14,15] Two studies 
analysed direct costs,[13,17] one reported savings.[17] Where savings were found, the 
reduction in the number of hospital admissions was considered to be the greatest source of 
economic gain. 
 
 
 
 
DISCUSSION 
Principal findings 
The principal findings of this systematic review is that the evaluations of home telemonitoring 
to date are of low quality and are undertaken by those who are enthusiastic about the 
potential of remote patient assessment. The low quality does not stem entirely from the 
finding that the trials are small and therefore underpowered – they also suffer from a lack of 
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clarity about a clear patient population. This lack of clarity results in heterogeneous 
populations where patients with COPD who are at risk of winter exacerbations are combined 
with other susceptible patients who are on oxygen or sometimes on mechanical respiratory 
support, as in Vitacca’s study.[14] These patients are not comparable in terms of the 
potential impact of remote motoring because the disease profile is so different. 
 
The telemonitoring interventions in each study differed widely. Some had an educational 
element directed at the patients and their carers that could itself account for the differences 
between groups. Few studies had a clearly stated aim for the telemonitoring intervention 
implemented. In general the telemonitoring intervention is poorly described, especially in 
terms of the assessment of the data transferred and how this assessment leads to a service 
response or not. The lack of a clear aim for the use of the intervention is manifested in the 
difficulty the trials have in specifying a clear primary outcome. The assumed, but not often 
declared, motive for using remote monitoring is to identify COPD exacerbations at a point in 
which it might be possible to intervene successfully, i.e. to reduce the risk of hospital 
admission by using appropriate therapy as soon as possible.  
 
The outcomes of a telemonitoring intervention are therefore: exacerbations (recognised and 
unrecognised) and their eventual outcome in terms of treatment (e.g. antibiotics, steroids, 
possible admission), and its eventual impact on service use. None of the trials included in the 
review made a distinction betweendistinguished health service contacts that were related 
specifically to COPD exacerbations.  The studies examined patient attendance at outpatient 
and emergency admissions (all cause), and so lack the ability to interpret the intended effect 
of the telemonitoring interventions. Many different outcome measures were reported. Only 
four of the six studies included physiological measures and the monitoring methods were not 
standardised or automated.  
 
Commented [w1]: Does this need a little more explanantion? 
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Despite these significant caveats, all the studies are positive about their results. However, 
given the inherent risk of bias in research of this nature and the low quality of the studies 
overall, with heterogeneous populations and diverse outcome measures, we conclude that 
the benefit of telemonitoring for COPD is not yet proven and that further work is required 
before wide scale implementation be considered.  
 
 
Strengths and weakness of this review 
Recently, there has been a systematic review and meta-analysis of telehealth in COPD,[20] 
with different inclusion criteria and importantly including telephone support studies (n=6). We 
are not aware of any previous attempt to conduct a systematic review of telemonitoring 
alone.  Our search process was extensive and rigorous.[12] Although we did not include 
unpublished articles, given the paucity of research we did include quasi-experimental 
studies. We did not conduct a meta-analysis due to the heterogeneity of the data and study 
designs. Systematic reviews of telemonitoring used in a range of other conditions have 
concluded that telemonitoring is a promising approach and conclude that using technology to 
remotely monitor patients at home is acceptable and easily implemented;[7,8,9]  and yet 
there is little progress on integrating telemonitoring into mainstream care. Moreover, unlike 
the situation in heart failure,[3,4,5] fewer rigorous studies have evaluated the efficacy of 
telemonitoring for COPD patients.  
 
Results in context  
There are no other systematic reviews of telemonitoring for COPD. Smith has however 
published a narrative review recently which came to the view that although there was 
‘potential for telemonitoring’ to improve care for patients with COPD the evidence to data 
does not confirm clear benefits.[1]. This view was echoed by McKinstry who has called for 
more ‘effectiveness’ trials and is part of a collaboration who have published a protocol 
describing a trial which has been designed to address the outstanding issues of exacerbation 
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definition, outcome measurement and cost-effectiveness.[10,21] Cooper draws similar 
conclusions in an editorial targeted at respiratory specialists which indicates the need to 
define very clearly what is meant by monitoring technology and what degree of automation of 
data collection and analysis would be consistent with the view that the technology is 
independent of clinical judgement or whether in the final analysis, the data from sensors will 
never be sufficient to guide the need or not to take clinical action.[22] 
 
Implications 
We therefore agree that the potential for telemonitoring is tangible but that there is much 
more work needed to determine the clinical benefit of early detection and theat “one glove fits 
all” approach seems too simplistic for this heterogeneous population of patients. A 
constellation of changing set of symptoms and signs that reveal themselves from a baseline, 
which itself shifts over time, and which can reliably establish the patient clinical status in 
order to enable a specific management plans demands detailed attention to a diagnostic, or 
even a prognostic, signature. Future trials involving telemonitoring for COPD need to have 
improved designs and more rigorous attention to intervention specification and overall aim, to 
outcome definition, measurement and economic analyses. We note that there is no evidence 
that these interventions are being embedded in routine clinical care. 
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Table 1.    Characteristics of Studies on Home Telemonitoring in Patients with COPD 
 
1st Author 
(Year) 
 
Design 
(Eviden
ce 
Score) 
Included patients, 
Sample & Power 
Calculation 
Intervention Follow-up 
months 
Economic 
Evaluation 
Results 
Dang  
(2006) (18) 
UBA 
(4) 
Overall sample 59 † 
(COPD, DM and CHF). 
COPD N=17 male 
veterans aged > 60 yrs.  
Power calculation not 
performed.    
Automated system logged patients’ 
self-reported symptoms and 
provided illness education. Referral 
alerts were generated if patients’ 
status changed.  
6 No No significant differences in the number of 
bed days of care, outpatient visits, hospital 
admissions or emergency department visits. 
 
Koff 
(2009) (13) 
 
RCT 
(2b) 
 
COPD Gold Stage 3 or 4.: 
Intervention: N = 19, 55% 
female, mean age = 67 
yrs 
 
Intervention: Patients transmitted 
self-reported symptoms, oximetry 
and spirometry readings to a 
central record system. Daily 
 
3 
 
RC 
 
Significant difference in St George’s 
Respiratory Questionnaire scores between 
groups.  Data on exacerbations in control 
group not collected. No savings in medical 
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Control: N = 19, 50% 
female, mean age = 65 
yrs 
Power calculation 
reported. 
completion of illness education and 
disease management modules. 
Contact with coordinator via mobile 
phone. 
Control: Usual care. 
costs reported; no adjustment for 
intervention costs. 
Maiolo (2003) 
(17) 
UBA 
(4) 
N=20 †, with COPD and 
on long-term oxygen, 9% 
female, mean age = 73 
yrs.  
No power calculation 
reported. 
Twice weekly nocturnal pulse 
oximetry readings sent via 
telephone line to a central storage 
system. Scheduled calls by 
physician to patient after analysing 
the oximetry data. 
 
12 RC Significant decrease in the number of 
hospital admissions (2.15 vs 1.21 
admissions, in Phase 1 vs. Phase 2 
respectively. (p<.01). 
Pare 
(2006) (15)  
NCBA 
(4) 
Patients with respiratory 
failure, emphysema and 
asthma. intervention: N = 
19, 37% female, mean 
age = 69 yrs 
Intervention: Patients transmitted 
peak flow symptoms and 
medication data. 
Control: Usual homecare. 
Both groups had access to a 
6 CMA Significantly fewer hospital admissions in 
the intervention group than the control in the 
6 month study, 2 vs. 6, (p<.05). However, 
when the intervention patients were 
admitted, the duration was significantly 
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Control: N = 10, 50% 
female, mean age = 72 
yrs 
No power calculation 
reported. 
 
nurse-led telephone service. longer, 13.5 vs. 7.3 days (p<0.01). Reported 
cost saving of $355 per person. 
Trappenburg  
 (2008) (16) 
NCBA 
(4) 
COPD patients GOLD 3 
and 4: Intervention: N = 
59, 54% female, mean 
age = 69 yrs 
Control:  N = 56, 39% 
female, mean age = 70 
yrs 
No power calculation 
reported. 
Intervention: Patients transmitted 
symptoms and medication data.  
Illness education and disease 
management training was 
provided.  
Control: Usual care. 
6 No Reported statistical difference in number of 
exacerbations (p<0.004) and hospital 
admission in intervention group compared to 
control group p<0.02) but the numbers of 
events are low. No significant differences in 
quality of life scores, number of inpatient 
days or outpatient visits. 
Vitacca 
 (2009) (14) 
RCT 
(2b) 
Patients on home 
mechanical ventilation or 
Intervention: Regular telephone 
appointments with a nurse where 
3-12 CMA Significant decrease in the average number 
of hospital admissions in the intervention 
 19 
on long term oxygen 
therapy. Intervention: N = 
57 
Control: N = 44. † 
No other details by 
diagnosis. 
Power calculation not 
performed. 
patients gave oximetry readings 
and reported their symptoms. 
Access to call centre. 
Control: Usual care. 
group (p<0.02). Patients in the intervention 
group showed a greater probability of 
remaining free of emergency visits (p<.001), 
GP calls (p<.02) and exacerbations 
(p<.001). No differences in mortality rates. 
Telemonitoring costs 50% cheaper per 
patient. 
 
Abbreviations: 
UBA Uncontrolled Before and After Study 
NCBA Non-Randomised Controlled Before and After Study 
RCT Randomised Clinical Trial 
CMA Cost Minimization Analysis 
RC Reported Costs 
† Study including patients with multiple diagnoses: results reported here only for COPD patients. 
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Table 2       The components of the telemonitoring intervention among the included studies 
 
Reference Measurement Parameters Recording of 
Biomarkers 
Call/ 
Web 
Centre 
Accessa 
Data Transmission Assessment Process 
Spirometer Pulse 
Oximeter 
Peak 
Flow 
 
Symptom 
Report 
Nurse Patient Auto Video Verbal Auto 
Alert 
Lay 
Person 
Clinician 
Dang  
(2006) (18) 
   ●   ● ●  ● ● ●  
Koff 
(2009) (13) 
● ●  ●  ●  ●   ●  ● 
Maiolo 
(2003) (17) 
 ●  ●  ●  ●  ●   ● 
Pare 
(2006) (15)  
  ● ●  ● ● ●  ● ●  ● 
Trappenburg  
 (2008)  
   ●    ●   ●  ● 
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(16) 
Vitacca 
 (2009) (14) 
 ●  ●  ● ●   ●   ● 
a Patients could contact these centres with a health related query when required. Typically, call centres were staffed for 8 hours a day, 5 days a week. Outside of these 
hours, an automated service was provided  
Cells are left blank where information on the components was not available 
 
